Theophylline-associated status epilepticus in an infant: Pharmacokinetics and the risk of suppository use

World Journal of Pediatrics

Volumn 5, Issue 4, 2009, Pages 316-318

  Kato, Zenichiro ^a   Yamagishi, Atsushi ^a   Nakamura, Mitsuhiro ^b   Kondo, Naomi ^a  

^a GIFU UNIVERSITY   (Japan)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Convulsion; Pharmacokinetics; Suppository; Theophylline

Indexed keywords

AMINOPHYLLINE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; DIAZEPAM; LACTATE DEHYDROGENASE; LIDOCAINE; THEOPHYLLINE; THIOPENTAL;

ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD GAS ANALYSIS; BRONCHITIS; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DROWSINESS; DRUG BLOOD LEVEL; EPILEPTIC STATE; HUMAN; INFANT; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; PARESIS; SUPPOSITORY; SUSTAINED DRUG RELEASE; TACHYCARDIA; TACHYPNEA; TONIC SEIZURE; TREATMENT RESPONSE;

AMINOPHYLLINE; BRONCHODILATOR AGENTS; DELAYED-ACTION PREPARATIONS; HUMANS; INFANT; MALE; STATUS EPILEPTICUS; SUPPOSITORIES; THEOPHYLLINE;

EID: 73349137334     PISSN: 17088569     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12519-009-0061-y     Document Type: Article

References (10)

1. D.W. Dunn H.U. Parekh 1991 Theophylline and status epileptics in children Neuropediatrics 22 24 26 10.1055/s-2008-1071410 1:STN:280:DyaK3M3ks1ensw%3D%3D 2038423
2. A.C. Nolke 1956 Severe toxic effects from aminophylline and theophylline suppositories in children JAMA 161 693 697 1:STN:280:DyaG28%2FntFCksw%3D%3D
3. T. Ooniwa K. Kuwahata T. Matsumoto K. Watanabe K. Yamashita H. Shinya, et al. 1985 The Clinical Report 19 444 454
4. Z. Kato O. Fukutomi M. Yamazaki N. Kondo N. Imaeda T. Orii 1994 Prediction of steady-state serum theophylline concentration in children by fi rst-order and zero-order absorption models Int J Clin Pharmacol Ther 32 231 234 1:STN:280:DyaK2M%2FgsFOnsg%3D%3D 7921516
5. Z. Kato K. Yasuda N. Shimozawa N. Kondo T. Horiuchi 1997 Theophylline-associated status epilepticus resulting in quadriplegia Ann Allergy Asthma Immunol 78 332 1:STN:280:DyaK2s3kt1WjtA%3D%3D 9087162
6. Z. Kato O. Fukutomi N. Kondo 1998 Developmental changes of unbound theophylline Ann Allergy Asthma Immunol 80 517 1:STN:280:DyaK1czgvFCqsw%3D%3D 9647276
7. Z. Kato O. Fukutomi N. Kondo 2002 Intrinsic factors for unbound theophylline J Investig Allergol Clin Immunol 12 217 219 1:CAS:528: DC%2BD3sXot1ejtg%3D%3D 12530123
8. H. Yoshikawa 2007 First-line therapy for theophylline-associated seizures Acta Neurol Scand Suppl 186 57 61 10.1111/j.1600-0404.2007.00810.x 1:STN:280:DC%2BD2srhvVOrtw%3D%3D 17784538 (Pubitemid 46376172)
9. W. Haruyama T. Fuchigami Y. Noguchi A. Endo K. Hashimoto Y. Inamo, et al. 2008 The relationship between drug treatment and the clinical characteristics of febrile seizures World J Pediatr 4 202 205 10.1007/s12519-008-0037-3 18822929
10. Medical Economics Staff. Drug information for the health care professional: USP DI, 15th ed, Macromedix, 1995.